Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FFF7G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,753
Award facts
- Contract value 100% obligated
- $37,753.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $37,753.30, was awarded to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The award was made by the Defense Logistics Agency (DLA) under a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with completion scheduled for October 29, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the U.S. military healthcare system.
Repatha is a prescription injectable medication used to treat high cholesterol and reduce cardiovascular risk in certain patient populations, making this a specialty pharmaceutical product supporting the Defense Health Agency's medical supply requirements. AmerisourceBergen's role as a major pharmaceutical distributor and healthcare solutions provider positions it as a critical vendor for federal medical procurement, with its extensive federal contract portfolio demonstrating capability to deliver a wide range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to military and veteran healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FFF7G?
SPE2DR26FFF7G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FFF7G worth?
The government has obligated $37,753 on SPE2DR26FFF7G.
Is contract SPE2DR26FFF7G an order under another contract?
Yes. SPE2DR26FFF7G is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFF7G competed?
The extent of competition for SPE2DR26FFF7G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award